|1.||Herbert, Z: 1 article (10/2008)|
|2.||Sivukhina, E: 1 article (10/2008)|
|3.||Sendemir, E: 1 article (10/2008)|
|4.||Zermann, D-H: 1 article (10/2008)|
|5.||Jirikowski, G F: 1 article (10/2008)|
|6.||Arnold, R: 1 article (10/2008)|
|7.||Aruldhas, M M: 1 article (02/2001)|
|8.||Ravichandran, K: 1 article (02/2001)|
|9.||Arunakaran, J: 1 article (02/2001)|
|10.||Maran, R R: 1 article (02/2001)|
|1.||Androgen-Insensitivity Syndrome (Testicular Feminization)
11/01/1984 - "Using conditions for optimal recovery of androgen receptor from human testes established by previous studies, we detected the presence of a high-affinity (dissociation constant = 3.2 X 10(-10) mol/L), low-capacity (4.2 X 10(-12) mol/mg DNA), androgen-binding protein when tritium-labeled R1881 was incubated at 4 degrees C with nuclear extracts from the gonads of control patients or from a patient with testicular feminization syndrome but not when incubated at 37 degrees C. "
08/01/1999 - "Duration-dependent effect of transient neonatal hypothyroidism on sertoli and germ cell number, and plasma and testicular interstitial fluid androgen binding protein concentration."
08/01/1999 - "Impact of neonatal onset hypothyroidism on Sertoli cell number, plasma and testicular interstitial fluid androgen binding protein concentration."
02/01/2001 - "We have previously demonstrated that neonatal and transient neonatal hypothyroidism modulates Leydig, Sertoli, and germ cell numbers, sex steroids and androgen binding protein concentration. "
10/01/1989 - "Hypothyroidism, induced by oral administration of methimazole from the day of birth, was characterized by a severe retardation of body and testis growth and a net inhibition of the increase in Sertoli cell gamma-glutamyl transpeptidase (GGT) activity as well as in androgen-binding protein (ABP) and lactate production, which normally occur during postnatal development of Sertoli cells. "
|3.||Hydatidiform Mole (Molar Pregnancy)
06/01/1983 - "We further studied the androgen-binding protein (ABP) that we recently evidenced in the serum from two patients with hydatidiform mole [Ref. "
10/01/1981 - "Extracts of hydatidiform mole vesicles and the fluid contained in these vesicles were shown to contain a trophoblastic androgen binding protein. "
10/01/1981 - "Evidence for the existence of an androgen binding protein in hydatidiform mole vesicles."
06/01/1983 - "Further evidence for distinction between sex hormone-binding globulin and an androgen-binding protein in hydatidiform mole serum."
12/01/1986 - "The trophoblastic androgen-binding protein (t-ABP) was purified 150-fold with a recovery of 51% from serum of patients with hydatidiform mole using various chromatographic techniques, successively affinity on concanavalin A, ion exchange on QAE-Sephadex A 50, gel filtration on Sephadex G 200 and chromatofocusing. "
|4.||Body Weight (Weight, Body)
04/01/1984 - "If related to constant body weight, the sum of testicular and epididymal androgen-binding protein was identical in both normo- and hyperglycaemic animals. "
07/01/1988 - "Body weight, testis, epididymis, prostate and seminal vesicle weights, the number of germ cells and Sertoli cells, tubular ultrastructure, epididymal and testicular levels of biologically active androgen-binding protein (ABP), and the plasma concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone were monitored. "
07/01/1993 - "The relationship of the testicular distribution and [3H]dihydrotestosterone-binding capacity of androgen-binding protein (ABP) to the completion of spermiogenesis was examined in mature rats given daily injections of 25 or 250 micrograms kg-1 body weight of GnRH antagonist (GnRH-A; Ac-D(2), Nal1, 4Cl-D, Phe2, D-Trp3, D-Arg6, D-Ala10) for two weeks with or without subcutaneous implantation of 10 cm testosterone capsules. "
|5.||Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
10/01/1976 - "An androgen binding protein in the cyst fluid of patients with polycystic ovary syndrome."
05/01/1986 - "A sensitive radioimmunoassay was used to measure the main androgen binding protein, testosterone-estradiol-binding globulin, in 13 patients with hirsutism and the polycystic ovary syndrome. "
|3.||Androgen Receptors (Androgen Receptor)
|4.||DNA (Deoxyribonucleic Acid)
|6.||Sex Hormone-Binding Globulin
|9.||Complementary DNA (cDNA)
|10.||Oxytocin Receptors (Oxytocin Receptor)